41
Participants
Start Date
November 4, 2019
Primary Completion Date
March 17, 2020
Study Completion Date
July 13, 2020
OsrHSA 20 mg/kg IV
A single dose of OsrHSA 20 mg/kg IV infusion at a rate lower than 2 ml/min
OsrHSA 40 mg/kg IV
A single dose of OsrHSA 40 mg/kg IV infusion at a rate lower than 2 ml/min
OsrHSA 80 mg/kg IV
A single dose of OsrHSA 80 mg/kg IV infusion at a rate lower than 2 ml/min
OsrHSA 140 mg/kg IV
A single dose of OsrHSA 140 mg/kg IV infusion at a rate lower than 2 ml/min
OsrHSA 200 mg/kg IV
A single dose of OsrHSA 200 mg/kg IV infusion at a rate lower than 2 ml/min
Placebo
Normal Saline (0.9% Sodium Chloride)
WCCT Global, Inc, Cypress
Lead Sponsor
Healthgen Biotechnology Corp.
INDUSTRY